I'm working on this now. Happy to discuss.
Sent from my iPhone. Please excuse brevity & errors.
The information in this email, including any attachments, may contain information that is confidential, privileged or proprietary and may be subject to protection under the law, including the Health Insurance Portability and Accountability Act (HIPAA). If you are not the intended recipient or have received this message in error, then you are strictly prohibited from reading, printing, retaining, copying or disseminating this message, any part of it, or any attachment. Please delete this message and any attachments from your computer without reading the content and notify the sender immediately of the inadvertent transmission.
-- NOTICE: This message and any attachments are intended solely for the individual or entity to which they are addressed. The information contained in this transmission may contain information that is privileged, confidential or exempt from disclosure under applicable law (e.g., patient information, financial information). If you are not the intended recipient, any review, dissemination, distribution, or duplication is strictly prohibited; please notify the sender by replying directly to this email, and please destroy all copies of the original message.
Original Message:
Sent: 2/12/2021 9:04:00 AM
From: Laura O'Hara
Subject: SBI - Recent annoument COVID-19 Vaccination
After the Society of Breast Imaging posted considerations for the management of axillary adenopathy in patients with recent COVID-19 vacation, are there any groups who are preparing statements for their patients?
https://www.sbi-online.org/Portals/0/Position%20Statements/2021/SBI-recommendations-for-managing-axillary-adenopathy-post-COVID-vaccination.pdf
------------------------------
Laura O'Hara
Red Bank Radiologists Business Manager lohara@redbankrad.com 732 741 9595 732 859 6718 Little Silver NJ
------------------------------